Cargando…
Cardamonin reduces chemotherapy resistance of colon cancer cells via the TSP50/NF-κB pathway in vitro
It has previously been reported that cardamonin is able to regulate glycometabolism and vasodilation whilst also exhibiting anti-inflammatory and antitumor properties. The antitumor effect of cardamonin is multifaceted, and so it is necessary to investigate the antitumor mechanisms of cardamonin at...
Autores principales: | Lu, Sen, Lin, Caizhao, Cheng, Xiaobin, Hua, Hanju, Xiang, Tao, Huang, Yu, Huang, Xi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6004643/ https://www.ncbi.nlm.nih.gov/pubmed/29928339 http://dx.doi.org/10.3892/ol.2018.8580 |
Ejemplares similares
-
Cardamonin reduces chemotherapy-enriched breast cancer stem-like cells in vitro and in vivo
por: Jia, Deyong, et al.
Publicado: (2015) -
Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma
por: Li, Yuting, et al.
Publicado: (2017) -
Cardamonin inhibits colonic neoplasia through modulation of MicroRNA expression
por: James, Shirley, et al.
Publicado: (2017) -
Retraction Note: Cardamonin induces ROS-mediated G2/M phase arrest and apoptosis through inhibition of NF-κB pathway in nasopharyngeal carcinoma
por: Li, Yuting, et al.
Publicado: (2019) -
Protumoral TSP50 Regulates Macrophage Activities and Polarization via Production of TNF-α and IL-1β, and Activation of the NF-κB Signaling Pathway
por: Yang, Cheng, et al.
Publicado: (2015)